Reply to Garg et al, Smith et al, and Persichino and Miller

Affiliations

¹ University of Texas Medical Branch, Galveston.
² Albert Einstein College of Medicine, Bronx, New York.
³ Christian Medical College, Vellore.
⁴ Dayanand Medical College, Ludhiana, India.
⁵ Columbia University, New York, New York.
⁶ Instituto Nacional de Ciencias Neurologicas and Universidad Peruana Cayetano Heredia, Lima, Peru.
⁷ National Institutes of Health, Bethesda, Maryland.

Comment

A Clinton White Jr et al. Clin Infect Dis. 2018.

. 2018 Nov 13;67(11):1798.

doi: 10.1093/cid/ciy437.

¹ University of Texas Medical Branch, Galveston.
² Albert Einstein College of Medicine, Bronx, New York.
³ Christian Medical College, Vellore.
⁴ Dayanand Medical College, Ludhiana, India.
⁵ Columbia University, New York, New York.
⁶ Instituto Nacional de Ciencias Neurologicas and Universidad Peruana Cayetano Heredia, Lima, Peru.
⁷ National Institutes of Health, Bethesda, Maryland.

No abstract available

Comment on

Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).
White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, Garcia HH, Nash TE. White AC Jr, et al. Clin Infect Dis. 2018 Apr 3;66(8):1159-1163. doi: 10.1093/cid/ciy157. Clin Infect Dis. 2018. PMID: 29617787 Free PMC article. No abstract available.
Pregnancy Screening and Monitoring of Albendazole Therapy for Neurocysticercosis.
Persichino JG, Miller LG. Persichino JG, et al. Clin Infect Dis. 2018 Nov 13;67(11):1797-1798. doi: 10.1093/cid/ciy436. Clin Infect Dis. 2018. PMID: 29790912 No abstract available.
Diagnosis and Treatment of Neurocysticercosis: Issues That Need to Be Addressed.
Garg RK, Malhotra HS, Pandey S. Garg RK, et al. Clin Infect Dis. 2018 Nov 13;67(11):1796-1797. doi: 10.1093/cid/ciy434. Clin Infect Dis. 2018. PMID: 29790916 No abstract available.
Antiparasitic Dosing Discrepancy in the 2017 Neurocysticercosis Guidelines.
Smith EA, Marks G, Hirai-Yang A, Tran H. Smith EA, et al. Clin Infect Dis. 2018 Nov 13;67(11):1797. doi: 10.1093/cid/ciy435. Clin Infect Dis. 2018. PMID: 29790919 No abstract available.

1. Garg RK, Malhotra HS, Sudhakar Pandey S. Diagnosis and treatment of neurocysticercosis: issues that need to be addressed Clin Infect Dis. - PubMed
1. Garcia HH, Lescano AG, Gonzales I, et al. ; Cysticercosis Working Group in Peru Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis. Clin Infect Dis 2016; 62:1375–9. - PMC - PubMed
1. Garcia HH, Gonzales I, Lescano AG, et al. ; Cysticercosis Working Group in Peru Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis 2014; 14:687–95. - PMC - PubMed
1. White AC, Coyle CM, Rajshekhar V, et al. . Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2018; 66:1159–63. - PMC - PubMed
1. Qavi A, Garg RK, Malhotra HS, et al. . Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: a prospective follow-up of 60 cases with a review of 56 published cases. Medicine (Baltimore) 2016; 95:e4882. - PMC - PubMed